Close Menu
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Chase’s Points Boost on Flights Is a Massive Points Bust

July 1, 2025

Looking for an income stream for decades? Here’s how to emulate the Bobby Bonilla plan to get paid over time

July 1, 2025

What’s next for the ‘big, beautiful bill’?

July 1, 2025
Facebook X (Twitter) Instagram
  • Contact Us
  • Privacy Policy
  • Terms Of Service
Tuesday, July 1
Doorpickers
Facebook X (Twitter) Instagram
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking
Doorpickers
Home»Stock Market»Purdue Pharma secures litigation ceasefire after US Supreme Court ruling By Reuters
Stock Market

Purdue Pharma secures litigation ceasefire after US Supreme Court ruling By Reuters

July 11, 2024No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

By Dietrich Knauth

New York (Reuters) – Purdue Pharma has been granted a 60-day freeze on lawsuits against its owners, the Sackler family, by a U.S. court. This decision comes after a landmark Supreme Court ruling that overturned its bankruptcy settlement.

U.S. Bankruptcy Judge Sean Lane approved the injunction at a court hearing in White Plains, New York, stating that the litigation ceasefire will allow Purdue to renegotiate a comprehensive settlement regarding lawsuits alleging that its painkiller OxyContin contributed to the opioid addiction crisis in the United States.

The Supreme Court’s ruling on June 27 determined that Purdue Pharma’s bankruptcy settlement cannot protect the Sacklers, who did not file for bankruptcy themselves, from their involvement in the nation’s opioid epidemic.

This ruling has forced Purdue to revisit its bankruptcy plans after nearly five years and puts at risk the billions of dollars in funding that the company and the Sacklers had committed to addressing the crisis.

Lawsuits filed against Purdue and the Sackler family by various state and local governments, as well as individual plaintiffs, have accused them of contributing to the opioid crisis through deceptive marketing of OxyContin. The company had previously pleaded guilty to misbranding and fraud charges related to its marketing of the drug.

Purdue’s bankruptcy protection has halted the opioid-related lawsuits against the company since 2019, and this shield has now been extended to the Sacklers as well.

Marshall Huebner, Purdue’s attorney, announced plans for expedited mediation involving the Sacklers, government entities, and other stakeholders. He emphasized the importance of the 60-day negotiation period in reaching a new settlement to address opioid overdoses and addiction.

“Every day of delay comes at a tragic cost,” stated Huebner.

Despite the hope for a settlement expressed by several parties, there is a consensus that mediation should adhere to the proposed 60-day schedule.

During the hearing, Judge Lane appointed two mediators, including retired bankruptcy judge Shelley Chapman, to facilitate the settlement talks. If mediation fails, Purdue has indicated that a court-appointed committee representing creditors should be permitted to sue the Sacklers over allegations of financial misconduct.

The Sacklers have denied any wrongdoing and oppose the proposed litigation by creditors. They have expressed willingness to continue settlement negotiations but remain prepared to defend against litigation if talks break down.

© Reuters. FILE PHOTO: The U.S. Supreme Court building is seen in Washington, U.S., May 20, 2024. REUTERS/Evelyn Hockstein/File Photo

“No one is guaranteed a recovery in this court or any other court,” stated Gerard Uzzi, representing the Sackler family members.

Purdue’s previous bankruptcy settlement had widespread support but also faced criticism from individuals like Carrie McGaha, who highlighted the challenges faced by those affected by opioid addiction throughout the bankruptcy proceedings.

ceasefire Court litigation Pharma Purdue Reuters ruling secures Supreme
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

“They Don’t Know What The F**K They’re Doing” – Furious Trump Slams Israel As Fragile Ceasefire Crumbles

June 24, 2025

Appeals Court Halts Judge’s Order Requiring Musk To Hand Over DOGE Records

March 27, 2025

RFK Jr. Is Pushing Big Pharma Ad Ban – And Corporate Media Is Panicking

March 26, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Stocks will hit fresh highs in the next 4 weeks — but investors should be careful around this key date, Goldman’s trading desk says

August 19, 20240 Views

Crypto Market Crash Today : 28th FEB

February 28, 20250 Views

Is Risk-Off Positioning Signaling A Market Low?

April 19, 20251 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest
Personal Finance

Chase’s Points Boost on Flights Is a Massive Points Bust

July 1, 20250
Retirement

Looking for an income stream for decades? Here’s how to emulate the Bobby Bonilla plan to get paid over time

July 1, 20250
Economic News

What’s next for the ‘big, beautiful bill’?

July 1, 20250
Facebook X (Twitter) Instagram Pinterest
  • Contact Us
  • Privacy Policy
  • Terms Of Service
© 2025 doorpickers.com - All rights reserved

Type above and press Enter to search. Press Esc to cancel.